financetom
Business
financetom
/
Business
/
Teledyne Technologies Insider Sold Shares Worth $4,637,510, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Teledyne Technologies Insider Sold Shares Worth $4,637,510, According to a Recent SEC Filing
Nov 12, 2024 9:04 PM

02:23 PM EST, 11/12/2024 (MT Newswires) -- Melanie Susan Cibik, Executive Vice President, General Counsel, Chief Compliance Officer and Secretary, on November 08, 2024, sold 9,461 shares in Teledyne Technologies ( TDY ) for $4,637,510. Following the Form 4 filing with the SEC, Cibik has control over a total of 27,285 shares of the company, with 27,285 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1094285/000109428524000120/xslF345X05/wk-form4_1731438987.xml

Price: 490.35, Change: +2.73, Percent Change: +0.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DraftKings Insider Sold Shares Worth $26,545,315, According to a Recent SEC Filing
DraftKings Insider Sold Shares Worth $26,545,315, According to a Recent SEC Filing
Oct 3, 2024
03:11 AM EDT, 09/30/2024 (MT Newswires) -- Paul Liberman, Director, President, Global Technology and Product, on September 25, 2024, sold 643,654 shares in DraftKings ( DKNG ) for $26,545,315. Following the Form 4 filing with the SEC, Liberman has control over a total of 572,543 shares of the company, with 21,638 shares held directly and 550,905 controlled indirectly. SEC Filing:...
Fortress Biotech Files Registration Statement on Behalf of Selling Shareholders
Fortress Biotech Files Registration Statement on Behalf of Selling Shareholders
Oct 3, 2024
04:13 AM EDT, 09/30/2024 (MT Newswires) -- Fortress Biotech ( FBIO ) on Friday filed a registration statement for the offering of up to about 6.2 million shares of its common stock by certain selling shareholders. The prospectus covers the sale from time to time of shares of outstanding common shares and shares issuable upon warrant exercises. The company will...
Hercules Capital Insider Sold Shares Worth $1,958,640, According to a Recent SEC Filing
Hercules Capital Insider Sold Shares Worth $1,958,640, According to a Recent SEC Filing
Oct 3, 2024
03:08 AM EDT, 09/30/2024 (MT Newswires) -- Scott Bluestein, Chief Executive Officer, on September 26, 2024, sold 100,000 shares in Hercules Capital ( HTGC ) for $1,958,640. Following the Form 4 filing with the SEC, Bluestein has control over a total of 2,161,207 shares of the company, with 2,161,207 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1280784/000156218024006976/xslF345X05/primarydocument.xml Price: 19.82, Change: +0.07, Percent...
Alnylam Pharmaceuticals Says Investigational Drug Slowed ATTR Amyloidosis Progression
Alnylam Pharmaceuticals Says Investigational Drug Slowed ATTR Amyloidosis Progression
Oct 3, 2024
03:53 AM EDT, 09/30/2024 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) said Sunday two sets of data from a phase 3 study showed that its vutrisiran investigational drug for treatment for ATTR amyloidosis with cardiomyopathy slowed disease progression. The illness causes a gradual thickening of the cardiac wall and a deterioration in heart functions leading to possible cardiac stress....
Copyright 2023-2026 - www.financetom.com All Rights Reserved